Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justin M Oldham

Showing results (91-100 of 166) with videos related to

Pageof 17
Sort By:
The European Respiratory Journal|January 13, 2019
Telomere length and genetic variant associations with interstitial lung disease progression and survivalChad A Newton, Justin M Oldham, Brett Ley, et al.
The European Respiratory Journal|March 26, 2026
Nerandomilast in progressive pulmonary fibrosis: data from the whole follow-up period of the FIBRONEER-ILD trialMarlies S Wijsenbeek, Shervin Assassi, Arata Azuma, et al.
JCI Insight|February 18, 2025
CD103+ dendritic cell-fibroblast crosstalk via TLR9, TDO2, and AHR signaling drives lung fibrogenesisHannah Carter, Rita Medina Costa, Taylor S Adams, et al.
The European Respiratory Journal|December 22, 2022
Interstitial lung disease progression after genomic usual interstitial pneumonia testingSachin Chaudhary, S Sam Weigt, Manuel L Ribeiro Neto, et al.
American Journal of Respiratory and Critical Care Medicine|August 9, 2022
Validation of Proposed Criteria for Progressive Pulmonary FibrosisJanelle Vu Pugashetti, Ayodeji Adegunsoye, Zhe Wu, et al.
Chest|March 19, 2020
Derivation and Validation of a Diagnostic Prediction Tool for Interstitial Lung DiseaseJanelle Vu Pugashetti, Aleksander Kitich, Shehabaldin Alqalyoobi, et al.
BMJ Open Respiratory Research|September 14, 2023
Design of a phase III, double-blind, randomised, placebo-controlled trial of BI 1015550 in patients with progressive pulmonary fibrosis (FIBRONEER-ILD)Toby M Maher, Shervin Assassi, Arata Azuma, et al.
The European Respiratory Journal|August 17, 2023
Telomere length and immunosuppression in non-idiopathic pulmonary fibrosis interstitial lung diseaseDavid Zhang, Ayodeji Adegunsoye, Justin M Oldham, et al.
Chest|October 22, 2023
Associations of Plasma Omega-3 Fatty Acids With Progression and Survival in Pulmonary FibrosisJohn S Kim, Shwu-Fan Ma, Jennie Z Ma, et al.
Chest|October 2, 2017
Phenotypic Clusters Predict Outcomes in a Longitudinal Interstitial Lung Disease CohortAyodeji Adegunsoye, Justin M Oldham, Jonathan H Chung, et al.
Pageof 17

Showing results (91-100 of 166) with videos related to

Sort By:
Pageof 17
The European Respiratory Journal|January 13, 2019
Telomere length and genetic variant associations with interstitial lung disease progression and survivalChad A Newton, Justin M Oldham, Brett Ley, et al.
The European Respiratory Journal|March 26, 2026
Nerandomilast in progressive pulmonary fibrosis: data from the whole follow-up period of the FIBRONEER-ILD trialMarlies S Wijsenbeek, Shervin Assassi, Arata Azuma, et al.
JCI Insight|February 18, 2025
CD103+ dendritic cell-fibroblast crosstalk via TLR9, TDO2, and AHR signaling drives lung fibrogenesisHannah Carter, Rita Medina Costa, Taylor S Adams, et al.
The European Respiratory Journal|December 22, 2022
Interstitial lung disease progression after genomic usual interstitial pneumonia testingSachin Chaudhary, S Sam Weigt, Manuel L Ribeiro Neto, et al.
American Journal of Respiratory and Critical Care Medicine|August 9, 2022
Validation of Proposed Criteria for Progressive Pulmonary FibrosisJanelle Vu Pugashetti, Ayodeji Adegunsoye, Zhe Wu, et al.
Chest|March 19, 2020
Derivation and Validation of a Diagnostic Prediction Tool for Interstitial Lung DiseaseJanelle Vu Pugashetti, Aleksander Kitich, Shehabaldin Alqalyoobi, et al.
BMJ Open Respiratory Research|September 14, 2023
Design of a phase III, double-blind, randomised, placebo-controlled trial of BI 1015550 in patients with progressive pulmonary fibrosis (FIBRONEER-ILD)Toby M Maher, Shervin Assassi, Arata Azuma, et al.
The European Respiratory Journal|August 17, 2023
Telomere length and immunosuppression in non-idiopathic pulmonary fibrosis interstitial lung diseaseDavid Zhang, Ayodeji Adegunsoye, Justin M Oldham, et al.
Chest|October 22, 2023
Associations of Plasma Omega-3 Fatty Acids With Progression and Survival in Pulmonary FibrosisJohn S Kim, Shwu-Fan Ma, Jennie Z Ma, et al.
Chest|October 2, 2017
Phenotypic Clusters Predict Outcomes in a Longitudinal Interstitial Lung Disease CohortAyodeji Adegunsoye, Justin M Oldham, Jonathan H Chung, et al.
Pageof 17